Latest / JACC Specialty Journals
JACC: CardioOncology Pulse - Clinical Risk Mitigation, Pathophysiology, and Genetics of Anthracycline-Associated Cardiomyopathy
Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.